and consequently, efflux of tetracycline by TetA 5 . The first biosensor capable of detecting oxytetracycline production by Streptomyces rimosus was constructed in Escherichia coli based on the original TetR repressor 6 . TetR-like repressor-coding genes have been identified within or in the vicinity of secondary metabolite clusters in many Streptomyces, which implied their potential roles in sensing cluster-specific molecules. Some of such repressors were indeed confirmed to bind both the end products of cluster-specific biosynthetic pathways, and/or its precursors. One of the first examples that concerned TetR-like repressors responding to secondary metabolites other than tetracyclines was that of LanK, the repressor controlling landomycin biosynthetic pathway in Streptomyces cyanogenus 7 . This protein was shown to bind various landomycins with altered aglycon structure, as well as extremely low concentration of the final product, landomycin A. Consequently, the authors have suggested that LanK can be used to develop a biosensor for detection of landomycin-related compounds.
The Repressor function of SymR, a TetR-like protein encoded by the simocyclinone biosynthesis gene cluster of S. antibioticus, was shown to be abrogated upon its binding to either simocyclinone D8 or its precursor C4 8 . Recently, chlorothricin and its biosynthetic intermediates were shown to modulate binding of a TetR-like repressor ChlF1 to its target genes in the chlorothricin gene cluster of Streptomyces antibioticus 9 .
These findings prompted us to investigate if TetR-like repressors in Streptomyces can be used for development of robust biosensors, which would couple easily detectable expression of the reporter with the production of specific secondary metabolites. Such biosensor would represent a clear advantage over the earlier described reporter system that detects expression of the secondary metabolite biosynthesis genes, as described by Guo et al. for gaudimycin biosynthesis. 10 Indeed, our design would allow direct monitoring of the cluster-specific product, not just expression of its biosynthetic genes. Here, we present a proof-of-principle for such a biosensor, and argue that similar design can greatly assist in the genome-based biosprospecting for novel bioactive compounds in Streptomyces and other actinomycete bacteria.
RESULTS AND DISCUSSION

Identification of Poorly Expressed Secondary Metabolite Biosynthesis Gene Clusters in
Streptomyces lividans TK24. Analysis of the S. lividans TK24 genome 11 using online version of the software antiSMASH 3.0 12 revealed 27 gene clusters for the biosynthesis of secondary metabolites, but this number was amended to 29 after manual curation using BLAST searches ( Table S1 . We have focused our examination on the genes from the targeted clusters, which encode enzymes responsible for the assembly of secondary metabolite scaffolds, reasoning that such scaffolds would represent a minimal structure that TetR repressors could bind. Out of examined gene clusters, only those for coelimycin and undecylprodigiosine fulfilled the criteria of being expressed at very low levels and encoding TetR-like repressors.
Attempts on Construction of the Undecylprodegiosin Biosensor
First, we have focused on the undecylprodigiosin biosynthetic gene cluster (red, Figure 1A ), which has been characterized in quite some details 14 . These earlier studies, however, did not address the function of the divergently transcribed genes SLIV_09075 and SLIV_09080 located ca 9 kb downstream of redE. SLIV_09075 encodes a TetR-like repressor, and the SLIV_09080 gene product is similar to MMPL domain-containing transporters. Since the red cluster does not encode any transporters, it seemed logical to suggest that the SLIV_09075+SLIV_09080 pair is responsible for undecylprodigiosin efflux in response to the production of this compound, with the TetR-like repressor being the receiver of the signal.
Considering this, we PCR-amplified the putative promoter/operator region upstream of SLIV_09080, and placed it upstream of the bpsA reporter in an integrative plasmid. BpsA is a mono-modular non-ribosomal peptide synthetase responsible for the biosynthesis of the blue pigment indigoidine, which is easily detectable both visually and spectroscopically 15 . When the resulting putative undecylprodigiosin reporter plasmid pYQS042 (Table S1 ) was introduced into S. lividans TK24, no indigoidine production was observed in the recombinant strain, suggesting that the SLIV_09075-encoded repressor blocks expression of bpsA.
Protein RedD encoded by the SLIV_09220 gene in the red cluster of S. lividans was shown to be a positive activator of the undecylprodigiosin gene cluster in S. coelicolor 16 . Therefore, overexpression of RedD was expected to trigger biosynthesis of undecylprodigiosin in S.
lividans as well, to which the constructed biosensor would react. Consequently, genes encoding RedD (SLIV_09220) and another putative regulator of the LuxR family, RedZ (SLIV_09200) 14 in the red cluster were overexpressed in the recombinant S. lividans TK24 harboring reporter plasmid pYQS042. Overexpression of both redD and redZ led to apparent activation of undecylprodigiosin production (activation was more efficient upon overexpression of redD), while no production of indigoidine could be observed in the engineered strains. These results implied that the TetR-like repressor encoded by SLIV_09075 does not bind undecylprodigiosin, and its gene may not belong to the red cluster.
In the next attempt to construct undecylprodigiosin-specific biosensor, we decided to combine Table S1 : constructs pYQS065 and pYQS066, respectively). The wild type copy of the RedStrep1 was constructed, which lacks red and act clusters, but retains SLIV_09075. To delete both clusters in S. lividans TK24, an efficient deletion system based on the positive selection of double crossover events with bpsA reporter gene was used 14 (see Methods for details). Two RedStrep1-based recombinant strains were constructed, which harbored both the integrated reporter pYQS042, and a low-copy number autonomously replicating plasmid expressing HR1 or HR2 proteins under control of the ermE*p promoter (Table S2) . No indigoidine production was observed by these recombinant strains, which excluded the possibility that hybrid proteins had direct activator function and could outcompete the SLIV_09075-encoded repressor. In summary, hybrid proteins constructed here proved to be non-functional, prompting further studies toward robust design of the hybrid TetR-like repressors.
Construction of the Coelimycin-Specific Biosensor. Our failure to construct undecylprodigiosin-specific biosensor was mainly due to the fact that TetR-like repressor encoding gene located at the border of the red cluster apparently had no function in the biosynthesis of this antibiotic. To establish a proof of concept, we next focused on the coelimycin gene cluster (cpk) for biosensor development, since this compound has never before been identified in S. lividans, while methods for its detection were available from the earlier reports on the closely related strain S. coelicolor M145. 21 . Coelimycin is a polyketide alkaloid, the biosynthetic gene cluster for which in S. coelicolor is silent, but can be activated upon deletion of the scbR2 repressor gene 22 . In S. coelicolor, scbR2 is located proximal (but transcribed in opposite direction) to the gene scoT encoding a type II thioesterase that proved to be important for coelimycin biosynthesis in the latter organism 23 . In S. lividans TK24, the arrangement of genes is similar (Figure 2) , and it was safe to assume that the SLIV_06715-encoded repressor would control the expression of the divergently transcribed thioesterase II-encoding gene SLIV_06710. We PCR-amplified putative promoter/operator region upstream of SLIV_06710, and placed the bpsA reporter gene under its control in an integrative vector pSET152 24 . This reporter construct pYQS040 was integrated into the chromosome of S.
lividans RedStrep1. The reporter strain RedStrep1 [pYQS040] showed no indigoidine production in a range of conditions, indicating that the SLIV_06715-encoding repressor acts in trans, and blocks the transcription of the reporter gene.
Testing of the Coelimycin Biosensor Using Artificial Activation of the cpk Gene Cluster.
In order to obtain proof-of-principle for our biosensor system, we decided to force coelimycin production in the reporter strain RedStrep1 [pYQS040] using overexpression of a pathwayspecific regulator. The latter strategy was shown to be useful in genome mining aimed at the discovery of novel compounds 25 . However, this approach may lead to unexpected results, and were no longer producing indigoidine, thus confirming that the developed biosensor system indeed responds to the production of coelimycin (Fig. 2) .
To obtain a final proof of coelimycin production, we compared metabolic profiles of the recombinant strains S. strain when incubated in the R5A media, but not in SG. In these conditions, the biosensor did not react to the production of minute amounts of coelimycin P1, probably due to its efficient and rapid efflux from the cells. The accumulation of coelimycin P1 was not detected when strains were grown either in TSB, phage media or NL19 media. Under these conditions production of indigoidine by S. lividans RedStrep1 [pYQS040] was also not observed.
CONCLUSIONS
The genome mining approach has shown a considerable potential in discovery of novel microbial secondary metabolites 25 . Still, the metabolomes of prolific secondary metabolite producers are often very complex, precluding identification of cluster-specified compounds.
Biosensors coupled to the actual production of target compounds would be very helpful in streamlining the discovery process, eliminating non-producers from the screening. In a recent report Guo et al. constructed a reporter system linking the expression of genes for gaudimycin biosynthesis to a reporter system in Streptomyces 10 . However, authors have reported high percentage of false-positives which, while expressing a reporter, did not actually produced a target metabolite. Also, in some cases expression of biosynthetic genes does not correlate with the compound production, probably due to some obstacles affecting translation or posttranslational modification of biosynthetic enzymes 27 . In our study, TetR-like repressors and bpsA reporter gene were used to construct biosensors that would directly detect production of secondary metabolites. Apparently, success in construction of a functional biosensor depends on whether identified TetR-like repressor gene actually belongs to the biosynthetic cluster, and can bind the cluster-specified compound. In the case of coelimycin, we have obtained a proofof-principle, demonstrating the utility of such a biosensor, although we cannot exclude the possibility that biosensor may also react to some intermediates in the biosynthetic pathway. 
METHODS
Bacterial Strains, Plasmids, and Growth Conditions. Description of plasmids and bacterial strains used or generated during this study is provided in Tables S1 and S2 (Supporting Information), respectively. S. lividans TK24 was used as the wild-type strain. RedStrep 1 (act red) was constructed as shown on Figure S1 (Supporting Information)with the deletions of nt 2961047-2982325 (act cluster) and nt 2081767-2113444 (red cluster) in S. lividans TK24 genome 11 . The deletions were, were validated by genome sequencing. RedStrep 1 was used in this study to avoid the potential color disturbance due to production of pigmented antibiotics specified by the act and red clusters in S. lividans TK24.
Escherichia coli strains were grown in Luria-Bertani (LB) broth or on LB agar. XL1-blue was used for general cloning. ET12567 (pUZ8002) was used for intergeneric transfer of plasmids to Streptomyces with the standard procedure of conjugation 28 . Streptomyces spore preparation was obtained by growing on soy flour mannitol medium (SFM) at 30°C for 4−7 days.
Antibiotics were supplemented to growth medium at the following concentrations when applicable: ampicillin 100 µg/ml; apramycin 50 or 100 µg/ml; chloramphenicol 20 µg/ml; hygromycin 100 µg/ml; kanamycin 25 µg/ml; nalidixic acid 30 µg/ml, and thiostrepton 30 µg/ml. RNA quality and quantity was checked by an Agilent 2100 Bioanalyzer (Agilent Technologies, Böblingen, Germany) and Trinean Xpose system (Gentbrugge, Belgium) prior and after rRNA depletion by using the Ribo-Zero rRNA Removal Kit (Bacteria) (Illumina, San Diego, CA, USA). The TruSeq Stranded mRNA Library Prep Kit (Illumina, San Diego, CA, USA) was used to prepare the cDNA libraries, which were then sequenced in paired-end mode on an Illumina HiSeq 1500 system (San Diego, CA, USA) with 2 x 27 nt read length.
Read mapping, data visualization and analysis of gene expression.
Reads were trimmed to a minimum of 20 bases in length using Trimmomatic V0.33 29 . Mapping of the trimmed reads to the S. lividans TK24 genome sequence 10 was performed with Bowtie 2 using standard settings 30 . ReadXplorer 2.2.0 31 was used for visualization of short read alignments and calculation of transcripts per million reads (TPM) of every scaffold-building gene of a secondary metabolite gene cluster 32 .
DNA Manipulation. General DNA cloning, DNA digestion with restriction enzymes and plasmid transformation into Escherichia coli were performed as described in Sambrook et al.
33
.
PCR fragments were amplified using MasterAmp™ Extra-Long DNA Polymerase Mix and buffers (Epicentre, USA). The primers used in this study were described in Table S1 . Primers for PCR were designed using Clone Manager Professional Version 9 (Sci-Ed Software, USA).
To construct new vectors, PCR and vector fragments were assembled either by T4 DNA ligase or Gibson ligation 34 . Recombinant constructs were verified by DNA sequencing by GATC Biotech. Streptomyces genomic DNA was isolated using Wizard ® Genomic DNA Purification Kit (Promega, USA).
Construction of S. lividans
RedStrep1 strain. Two DNA fragments flanking the act cluster were PCR amplified from the genomic DNA of S. lividans TK24. A 2.7-kb DNA fragment flanking the 3′ end of SLIV_12925 (Fig. S1A) was amplified with the primers 12925Dir and 12925Rev (Table S4 ). This DNA fragment was digested using MfeI and ClaI and cloned into pAMR4 15 resulting in pAct1. A 3-kb DNA fragment flanking the 3′ end of SLIV_13030 (Fig.   S1 ) was amplified with the primers 13030Dir and 130130Rev (Table S4 ). This DNA fragment was digested with AflII and HindIII and cloned in pAcl1, resulting in pAct2. The plasmid was introduced into S. lividans TK24 by conjugation, and after several rounds of propagation bpsAnegative apramycin-resistant and kanamycin-sensitive colonies (indicating a double cross-over event) were selected. The replacement of the act cluster by apramycin-resistance cassette was confirmed by Southern-blot hybridization (data not shown). One clone (S. lividans act) was used for further deletion of the red cluster. Likewise, two DNA fragments flanking the red cluster were PCR amplified from the genomic DNA of S. lividans TK24. A 2.9-kb DNA fragment flanking the 5′ end of SLIV_09220 (Fig. S1A) was amplified with the primers 9220Dir and 9220Rev (Table S4) , digested with MfeI and BamHI and cloned into pSPR11, resulting in pRed1. The cloning vector pSPR11 was prepared by replacing the apramycin-resistance gene aac(3)IV in pAMR4 with synthetic spectinomycin-resistance gene aadA from the plasmid paatsaadA-oriT, containing oriT and P-GG and G-CC recombination sites for phiC31 recombinase 35 . A 3-kb DNA fragment flanking the 3′ end of SLIV_13030 (Fig. S1A) was amplified with the primers 9115Dir and 9115Rev (Table S4) , digested with AflII and HindIII and cloned in pRed1 resulting in pRed2. The plasmid was introduced into S. lividans act by conjugation with selection for spectinomycin resistance. After several rounds of sporulation, four bpsA-negative spectinomycin-resistant and kanamycin-sensitive colonies were selected, and the correct double crossover event in the red cluster was confirmed by Southern-blot hybridization (data not shown). One S. lividans act red clone was used for further studies.
Both antibiotic resistance markers, the apramycin resistance marker with FRT sites for recombination 36 , and the spectinomycin resistance marker with B-CC and P-GG sites for recombination, were removed from the S. lividans act red strain by successive transformation of the plasmid pUWLHFLP, containing Flp recombinase 37 Table S3 , Supporting Information) and joined using Gibson ligation. 35 The resulting fragments were cloned into the pKC1218HygR vector under control of ermE*p promoter, and verified by DNA sequencing.
Analysis of Secondary Metabolites produced by the Recombinant Strains. Strains were grown for 3 days at 28 °C in 10 ml of TSB medium. Subsequently, 4 ml of the pre-culture was used to inoculate 50 ml of production media in 500 ml flasks: NL19, SG, R5A or phage medium.
The main cultures were cultivated at 28 °C on a rotary shaker at 180 rpm for 5 days. Metabolites were extracted with acetone:methanol 1:1 from biomass and with ethyl acetate from cultural liquid, solvents were evaporated and extracts were dissolved in 300 μl of methanol.
Samples were separated on a Dionex Ultimate 3000 RSLC system (Thermoscientific ) using a BEH C18, 100 x 2.1 mm, 1.7 µm dp column (Waters) with linear gradient of solvent B 
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Supporting Information: Figure S1 (construction of S. lividans RedStrep1 strain), Figure S2 (identification of coelimycin P1), Tables S1−S4 (descriptions of bacterial strains, plasmids, oligonucleotides, supporting main text). when grown in SG medium. The peak presumably corresponding to coelimycin P1 is indicated by arrow. More detailed analysis, including MS/MSbased identification of coelimycin P1, was done as reflected in Figure S2 (Supporting Information).
